Lapatinib Completed Phase 1 Trials for HER-2 Gene Amplification Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01304784A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer